. Author manuscript; available in PMC: 2010 Mar 11.

Published in final edited form as: J Lipid Res. 2007 Dec 29;49(4):832–846. doi: 10.1194/jlr.M700598-JLR200

TABLE 3.

Observed maximum and final amounts of OxPAFs and LA-PAF

	Maximum		Final

Phospholipids	Amount pmol	Yield %	Amount pmol	Yield %
LA-PAF	15.0 × 10³	100	1.35	9.01
ON-PAF	109.7	0.73	101.3	0.68
A-PAF	203.9	1.36	203.9	1.36
KODA-PAF	154.2	1.03	42.7	0.28
HODA-PAF	112.2	0.75	79.9	0.53
KDdiA-PAF	82.7	0.55	82.7	0.55
KHdiA-PAF	35.4	0.24	35.4	0.24

A-PAF, 1-O-hexadecyl-2-azeleoyl-sn-glycero-3-phosphatidylcholine; HDdiA-PAF, 1-O-hexadecyl-2-(11-carboxy-9-hydroxyundec-10-enoyl)-sn-glycero-3-phosphatidylcholine; HODA-PAF, 1-O-hexadecyl-2-(9-hydroxy- 12-oxododec-10-enoyl)-sn-glycero-3-phosphatidylcholine; KDdiA-PAF, 1-O-hexadecyl-2-(11-carboxy-9-oxododec-10-enoyl)-sn-glycero-3-phosphatidylcholine; KDdia-PAF, 1-O-hexadecyl-2-(6-carboxy-4-oxohex-5- enoyl)-sn-glycero-3-phosphatidylcholine; KODA-PAF, 1-O-hexadecyl-2-(9-oxo-12-oxododec-10-enoyl)-sn-glycero-3-phosphatidylcholine; LA-PAF, 1-O-hexadecyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine; ON-PAF, 1-O-hexadecyl-2-(9-oxononanoyl)-sn-glycero-3-phosphatidylcholine. Each value is the average of two independent studies (n = 2), starting with LA-PAF (15 nmol).